text:
This is an entry-level position. Work involves writing presentence/predisposition reports and/or supervising clients placed on probation, as well as conducting juvenile intake interviews as needed.
Requirements include graduation from college with a bachelor's degree in the social sciences, criminal justice or related fields; ability to write the required reports, case plans, chronological notes; ability to communicate verbally with clients, judges, school personnel, law enforcement, families; ability to read and interpret police reports, mental health evaluations, chemical evaluations; ability to maintain workload of writing reports and supervising clients; appear in court; ability to motivate clients toward self-improvement.
The ability to speak Spanish is desired but not required.
A State of Nebraska application for employment must be received by the closing date/time.
Notify the Administrative Office (402-471-4140) for special accommodations relating to the American with Disabilities Act. For persons with hearing impairment, please call the Nebraska Relay System, 7-1-1. AA/EOE.


text:
Home » Budget Cuts
Budget Cuts by selloutphotos
Need a larger size? Contact Us
Purchase this royalty free image
UK VAT at 20.0% is charged if applicable.
The requirement for the licence purchased and the relevant releases is dependent on how you are going to use the image. It is your responsibility to determine whether a release is required for your intended use. You can contact us if you have any queries.
Image Details
Comments on this Image
No Comments on this image.
Royalty free stock image of Budget Cuts
Budget on a wooden desk with a pair of scissors, calculator, stapler, and paper clips

subset: commoncrawl


text:
Had Missouri youth hunt this past weekend and took my nephew to Bush Wildlife area near St. Louis. First day slid in early in the rain and heard 6-8 gobbling off the roost, but most of them pretty far away. We hunkered down and made a few calls, and had 5-6 hens pass about 80 yards away down a game trail in the woods where we were, they passed by in groups of 1-2 over a period of about an hour, and had a nice tom follow them at the end. Next day we set up close to that trail in the middle of 3 fallen trees about 30 yds from the crest of a hill. Heard 6-8 Toms again and started calling. One answered back from a good distance and we started a 'conversation'. Next thing I know we can hear 3 of them together and they are cutting off every call I make and they are coming from the other side of the hill, and LOUD, each trying to be louder than the others. We call back and forth about 6-8 times and each time all three cut me off and keep getting closer until I can hear that they are right over the crest of the hill. Then......nothing but silence.... We had a hen decoy connected to some fishing line so we could give her a little wiggle, and I don't know if they saw her and didn't like it or what, but we waited about a 1/2 hour and then I snuck up to the crest and there is a big flat up on the crest and there was nothing there...poof!
Later we walk about a cagillion (technical term) miles to the very back of the property and walked up a trail toward the top of a hill. I'm thinking we will get to the top and make a few calls, but halfway up a tom on the left side of the hill lights it up and he is close. I tell my nephew to plant it in front of a tree on the opposite side of the trail and I sit about 8ft to his right behind a bush, both facing where we heard him. I call a few times and soon he is cutting me off and coming hard. Next, he quiets up but after a few second I look to my right and not 8 ft away up the trail is a strutting tom and 2 jakes. I slowly turn my head, and clearly my nephew cannot see them on his right through the bush....GGRRRRR!!!!!! I slowly turn and motion to him and I think he sees them but doesnt move his gun and keeps looking forward. After a few seconds they smell a rat because there isn't a hen where they had heard something so they quickly exit stage right. After they are gone I ask him what was he doing? He said he was waiting for them to come the rest of the way down the trail, and he didn't know if he could shoot through the bush. 12 Ga #6 Hevi shot....um... from 15-20 feet I think it would have done the job. Oh well, at least it was exciting. He said he knows where he wants to go next year for youth hunt but I told him don't bother, uncle Jack plans on cleaning up after him next Monday when the MO regular season starts!!


text:
Results 1 to 2 of 2
Thread: Changes to Comp Rules
Changes to Comp Rules
As you may remember, we had a very very close race in MOTM this past month. According to the comp rules, we had a tie-breaking vote. That second vote almost resulted in another tie. The Mod team and myself have decided to up-date the comp rules to better hand these types of situations in the future.
Below is a summary of the changes made:
Ties in the Photo Comps:
Ties for first place will go heads up in a 3-day tie breaking poll. These polls take place from the 25th-28th, after which the winner is announced.
Members tied for second place in photo contests will all receive the reward of 10,000 points and second prize medal.
Those that come in second place after the tie will automatically win Runner-Up. If ties still remain after the tie-breaker vote, all winners are awarded for the place they are tied for, be it first or second.
Ties in MOTM voting:
In the case of a tie for MOTM, the award will go to both members. In the event of a tie between three or more members, a tie breaking vote shall be used.
Last edited by Cliff; 09-29-2012 at 12:01 PM.If you take your time to do the research FIRST, you can successfully set-up and keep ANY type of aquarium with ease.
"Not using a quarantine tank is like playing Russian roulette. Nobody wins the game, some people just get to play longer than others." - Anthony Calfo
Fishless Cycle Cycling with Fish Marine Aquarium Info [URL="http://saltwater.aquaticcommunity.com/"]
now all the high lander quotes of there can only be one arent going to work, but i think its fair that was some very close polling... i wouldnt have been surprised if it was another tie..... but now im having a vision of the future lolKING OF THE GOLD BARBS RAWR!!!!
I wonder if i plant one of my tiger barbs would the demon seed grow to a full tree?
gotta love them bunnies!
I.R.S.: We've got what it takes to take what you've got!


text:
Actually I don't think it is. It has to do with people being ignorant and ignoring facts.
i don't think you actually read what i wrote
However, your reference to "liberal science" is a bit bizarre and not obviously related to the original post.
Especially since both witchcraft and evolution denial are both superstition that is easily refuted by evidence.
we have some people even on this board who do not believe in evolution
Like the people who blame global warming on man and want us to drive bicycles?
Like people who want to ban guns and would rather us fight off criminals with sticks.
Like people who want to produce electric cars that no one wants and think windmills can replace oil for power?
Like people who want to use up our food supplies to make ethanol that uses more power to make than it produces?
Like people who believe food stamps stimulate the economy?
Like people who want to limit sugary drinks to 16oz for our own good?
Like people who say," we have to pass a bill to know what's in it"?
so are the negative effects of GMOs that are the same as superstition
so are the superstitions of the OWS idiots
"Liberal science" sounds like something 2013 made-up-Jesus would say.
None of these are science. I agree that most of these are as idiotic as evolution denial. They are also politics. And politics is even more idiotic than evolution denial.
Ignorance is in the eye of the beholder.
These are true believers who wake up every morning and have to ignore things every day to blindly believe in what they believe.
so are the superstitions of the OWS idiots
global warming issues are science-related
the issues relating to oil/energy adoption are science-related
GMOs/organic food issues are CERTAINLY science-related
the ows is simply the have nots attacking the haves.
quote:How can they be so ignorant even today? Are they just less intelligent? Is there any other viable explanation?
witch burned alive, feb 8, 2013
Let's pretend that those are actually based on real science. How is that related to evolution denial?
who decides what is real science and fake science?
Anyway, I don't really see how evolution is a "liberal vs conservative issue."
There are people who willfully ignorant. These are the so called young earthers.
outside of working in a field like geology, i don't see how they'd run into that much evidence D2D
Walking on a riverbed and seeing a fossil.
Reading anything in the press that has anything to do with science/religion/history even peripherally.
whenever any period in history is mentioned that goes back more than 6000 year, you have to ignore it.
How many times to you hear about light years away and how mnay light years away such and such thing is? If that thing happened at a distance of more than 6000 light years, well they are hosed.
Any sort of dinosaur outside of cartoons often mentions age. Whenever something is dated with a radioisotope, bam, can't believe in that.
When you hear of about an animal that is a relative from such and such, well that can't be. Because God just made them that way.
Advertising Info
Privacy Policy
Where to Watch LSU
Contact Us
© 2017 TigerDroppings.com. All Rights Reserved


text:
You are here
Date & Time
Event Details
Jazz Artists of Charleston announces programming for its 2nd Annual JAC Week, presenting five days of diverse programming and debut concerts to celebrate the work of JAC and the Charleston Jazz Orchestra, while raising awareness and funds to keep Charleston's jazz culture and legacy alive and thriving. Local saxophonist, Simon Harding, and pianist, Jordan Gravel, team up to bring back to life a classic album of jazz duets: Stan Getz and Kenny Barron's People Time. The album is the final recording made by legendary saxophonist Getz, and includes duet arrangements of 14 jazz standards. In honor of the dynamic power of this original pairing, Harding and Gravel revisit the music of People Time in an intimate, "pay-what-you-will" performance. There are two sets, 6pm and 8pm, with limited seating available. Call (843)641-0011 for reservations.


text:
Log In now to add this Gigapan to a group gallery.
Log In now to add this Gigapan to a gallery.
About This GigapanToggle
- Taken by
- Hawaii Pacific News
- Explore score
- 57
- Size
- 3.26 Gigapixels
- Views
- 6079
- Date added
- Apr 25, 2011
- Date taken
- Apr 24, 2011
- Categories
- Galleries
- Competitions
- Tags
- honolulu, restored, hpu, hpn, pacific, news, landmark, national, hall, queen, residence, historic, palace, iolani, opulence, mirrors, grand, drapery, hawaiian, hawaii, gold, royal, red, room, Throne, restoration, monarchy, king, oahu
- Description
'Iolani Palace
364 South King Street
Honolulu, HI 96813
Completed in 1882, 'Iolani Palace functioned as the official residence of Hawaii's monarchy. It was first known as Hale Ali'i meaning house of chief. However, Kamehameha V renamed it in honor of his brother. Io' translated means Hawaiian hawk and Lani signifies something heavenly or royal.
The location not only served as the residence for royalty but also the location to entertain dignitaries thanks to King David Kalakuau. It was his vision that brought the palace to fruition.
It also should be noted that King Kalakuau was the first to visit the United States and address congress. He negotiated duty free transport of sugar from the islands.
After Kalakuau's untimely death 1891, his sister Queen Lili'uokalani became the successor to the throne. She focused her efforts on returning political power to the monarchy and limiting the suffering of subjects by circulating a new constitution. However, it served to only infuriate and ignite strong opposition from the business community (made up of foreign nationals, Hawaiians whose parents were Americans, and plantation owners).
In 1893, Queen Lili'uokalani relinquished power to avoid bloodshed of her people. Though there was an attempt to restore power in 1895, it was to no avail. The newly founded government convicted the Queen of "having knowledge of the plot". They fined her $5000 and ultimately sentenced her to house arrest at the palace for 8 months.
The Palace served as capitol of the Provisional Government, Republic, Territory and State of Hawai`i until 1969. At that time the Palace was vacated and restoration begun.
Though the friends of Iolani palace have worked diligently over the to restore the palace to its original splendor, it should be noted that castle had some of the most advanced technology of its time. For instance, the palace had indoor plumbing, electricity that replaced gas chandeliers, and even the newly invented telephone system.
The restoration of the palace covers the first and second floors. The first floor includes the Grand hall, State dining hall, reception hall, and the Throne room. The second floor showcases the bedroom for Kalakuau, a music room, and the Kapiolani suite complete with several guest rooms. ]
The Throne room as pictured here is near the grand Hall. It is the location where King Kalakuau entertained guests. Incidentally, it is also the location for the trial of Queen Lili'uokalani.
Facts courtesy of iolanipalace.org
Architects: Thomas J. Baker, C.S. Wall, and Isaac Moore
Style: Italianate
National Register: 1966 #66000293 (1962 NHL)
Gigapan Comments (0)Toggle Minimize gigapan_comment
Where in the World is this GigaPan?Toggle
Stitcher NotesToggleMinimize
GigaPan Stitch version 1.0.0804 (Macintosh)
Panorama size: 3260 megapixels (97104 x 33580 pixels)
Input images: 495 (33 columns by 15 rows)
Field of view: 167.3 degrees wide by 57.9 degrees high (top=36.5, bottom=-21.3)
All default settings
Original image properties:
Camera make: OLYMPUS IMAGING CORP.
Camera model: E-620
Image size: 4032x3024 (12.2 megapixels)
Capture time: 2011-04-24 11:39:55 - 2011-04-24 12:27:51
Aperture: f/14
Exposure time: 0.2
Focal length (35mm equiv.): unknown
Digital zoom: off
White balance: Fixed
Exposure mode: Manual
Horizontal overlap: 25.2 to 41.0 percent
Vertical overlap: 23.4 to 41.5 percent
Computer stats: 3840 MB RAM, 2 CPUs
Total time 1:09:43 (8.5 seconds per picture)
Alignment: 14:10, Projection: 5:50, Blending: 49:43
(Preview finished in 27:49)


text:
Exhibition Press Materials
Thank you for visiting the Walters Art Museum Press Room.
Press materials for current and upcoming exhibitions are available by clicking on the appropriate links to the left.
For inquiries about media-related matters, please contact the Office of Public Relations.
Mona M. Rock
Manager of Public Relations
410-547-9000, ext. 277


text:
Family: Apiaceae, Carrot view all from this family
Description Perennial. Habit: erect, height to 7 ft, with a strong odor of anise. Leaf: wispy, finely dissected, up to 20 inches long. Flower: broad yellow umbel, 2-6 inch dia.
Flower May - September.
Habitat Found in large stands on disturbed sites and river banks.
Range Continental U.S.
Discussion Native to Europe. Introduced in colonial times as a culinary plant, fennel escaped cultivation and is now considered an invasive species in the continental U.S., Hawaii, and Canada.


text:
The history of one problematic dam in Oregon teaches how not to manage risk
Douglas Larson
In October 1988, shortly after the Eugene Register-Guard got wind of these results, Oregon's Senator Mark Hatfield became involved. At his behest, the Corps dispatched a special team of four senior-level engineers and a consulting concrete expert to Oregon to investigate. The engineers—hand-picked from headquarters staff in Washington, D.C.—worked for the Chief of the Directorate of Engineering and Construction, who had received a $10,000 Presidential award in 1987 for supervising the design and construction of Willow Creek dam, creating an obvious conflict of interest (which journalists and others involved somehow overlooked).
On arrival, the team spent some hours inspecting the dam before reviewing the scientific data. After just a few days of deliberation, the team boldly announced to the news media that "There is no reason for concern regarding the structural safety of the dam. The dam is indeed a reliably safe structure." The engineers then impugned the scientists' research, stating: "Criticism of the [roller-compacted concrete] design and construction concept is not warranted and without merit." And they killed my proposal for aeration by saying, "Despite the presence of hydrogen sulfide gas, there is no evidence that acid is wearing away the dam."
Senator Hatfield's office immediately issued a news release, which in part read: "Allegationsof health and safety problems at Willow Creek were quite serious. After a thorough study by Army experts, it appears reasonable to assert that these concerns were unfounded." On November 17, 1988, the Oregonian, Oregon's largest newspaper, published these declarations in a front-page story headlined: "Dam safe, experts agree."
Further efforts to end the debate quickly followed. Contrary opinion within the Corps was suppressed, and contracts with the outside scientists were not renewed, thus ending what to that point had been collaborative and productive research into the safety of the dam.
In July 1989, the scientists issued their final report, which detailed the deterioration of the roller-compacted concrete, but the Corps refused to release the document to the public. Journalists at the Eugene Register-Guard attempted to obtain a copy by filing a request under the terms of the Freedom of Information Act, but the Department of the Army's Assistant Chief Counsel for Litigation denied the request, claiming that release of the report "could discourage honest and frank discussions within the Corps." The Register-Guard decided not to appeal. The controversial document was, however, released in 1990, but it was appended to the Corps' own final report, which was clearly aimed to discredit the scientists' research methods and findings.
Community Guidelines: Disqus Comments
The Art and Science of Communicating Science
American Scientist Classics
Women in Science
Purchase a Back Issue
2014 Annual Index
The Age of Nuclear Weapons
25 Years in North Carolina
Related Letters to the Editors
Concrete Solutions
© 2016 Sigma Xi, The Scientific Research Society


text:
First, thank you to all the participants for making our AKC HT a success! We really appreciate everyone turning out to support our club!
50/50 Raffle winner- Marshall Richard, ticket #780665
Butch Green bird drying rack- George Strickler, ticket # 780501
A BIG THANK YOU to Butch for his generous donation! Your products are truly first class, functional and durable!- Paul


text:
Nana Perkins was a big influence in my life. While we were growing up, my twin brother and I spent a lot of time at her home next to the Grange Hall in Loudon, New Hampshire. We never knew our grandfather Perkins—he died before we were born.
For many years she was the Loudon town clerk and local correspondent for the Concord Monitor, the weekly newspapers published in Pittsfield and Laconia. I recall her using a rickety old typewriter to record the town events such as vital records, fishing and hunting licenses, etc.
Nana Perkins was a big Red Sox fan, but listened to any game she could on her radio (before she owned a television set). Because her home was always open (I don't recall that a door was every locked) to villagers, friends, and relatives, she occasionally felt a need to escape so no one would disturb her when an important baseball game was underway. When that happened, she put my brother and I in her car and drove us to a cemetery in a neighboring town. Once at the cemetery she'd ask Peter and I to get out of the car to play while she listened to the game on the car radio.
Following WWII our family moved in for a couple of years before my Dad got a job as a NH State Trooper and was transferred to the the Keene area. Peter and I started school in Loudon, we would walk up Main Street (now called South Village Road) in the village, past the library and over the Soucook River bridge and then up School Street to the one room school house.
It was Nana Perkins who originally got me involved in family history. She gave me a couple of town genealogy books that had belonged to her father and it wasn't long before I was hooked. I think, however, my early days playing in cemeteries helped nudge me that in direction as well.
Nana Perkins enjoyed using a needle and thread. She was always mending or piecing a quilt. It was Nana Perk who taught me to sew clothes. I remember sitting at her old Singer treadle machine when I was about ten years old making my very first outfit—a pair of shorts and halter-top made of printed blue cotton [see image at right].
The Grange was always a part of Nana's life. She regularly attending meeting of the Grange in Loudon. In the image to the left she is pictured receiving a special award. That was in 1975 when she was 89 years old.
When we were young, she saw to it that Peter and I became members of the Juvenile Grange and when my family moved from Loudon to Walpole about 1947, members of the Juvenile Grange gave us a "Going Away" party complete with several Golden books.
Alice Margaret Brown was the youngest of four children born to Alfred H. and Margaret (Gale) Brown. She and her three siblings, Josephine, Fred, and Mary grew up in Canterbury, New Hampshire. Their family home was called The Maples. The images below show the house and barn about 1991.
Oh, how I wish I had recorded the many stories she told me about her childhood.
Following her graduation from high school (I believe she attended the Keyser School in Canterbury, Alice taught school in Loudon where she roomed with the John Butters Perkins family. John's son, Homer, and Alice were wed in Chester, N.H. by Albert E. Hall, on the 8th of April 1908. The couple resided in Loudon and had two daughters, Helen and Josephine.
Nana moved to Keene, N.H. in 1964 to live with her daughter Helen. When Helen passed in 1976, my Mom moved in to the cottage on Boston Place until Nana decided it was time she moved into a senior residence. Nana Perkins died in Westmoreland, New Hampshire, 4 Jun 1984, at the age of 97.
I really miss her even though she's been gone so many years.
© Linda Woodward Geiger, All Rights Reserved.


text:
Kung Pao Broccoli and Tofu
Betsy DiJulio
The Blooming Platter Cookbook
Published by Vegan Heritage Press
The delicately fried tofu pairs well with the broccoli for a generous boost of calcium, protein, and vitamin C. Serve over freshly cooked jasmine or brown rice. For extra heat, add a few shakes of hot red pepper flakes if desired.
4 to 6 servings
Cooking Methodstir-frying
Total Timeunder 30 minutes
Recipe Coursemain course
Dietary Considerationegg-free, gluten-free, halal, kosher, lactose-free, tree nut free, vegan, vegetarian
Taste and Texturegarlicky, hot & spicy, nutty, umami
Type of Dishvegetable
- 4 tablespoons soy sauce
- 2 tablespoons rice vinegar
- 2 tablespoons dry sherry
- 6 tablespoons vegetable stock
- 1 tablespoon plus 1 teaspoon natural sugar
- 2 teaspoons brown rice syrup
- 1 tablespoon plus 1 teaspoon cornstarch
- ½ teaspoon toasted sesame oil, optional
- 1/3 cup cornstarch
- Sea salt
- 14 ounces extra-firm tofu, drained, pressed, blotted dry, and cut into 1-inch dice
- 2 tablespoons canola oil, plus more for frying
- 5 small hot dried chiles
- ½ cup roasted peanuts, plus more for garnish
- 1 clove garlic, minced
- 1 teaspoon grated fresh ginger
- 3 cups small broccoli florets
- 1 (8-ounce) can sliced water chestnuts, drained
- 2 scallions, cut into 1/2-inch pieces, plus more for garnish
For the Sauce: In a small bowl, combine all the cooking sauce ingredients. Mix well and set aside.
For the Tofu and Broccoli: Preheat the oven to 250ºF. In a medium bowl, whisk together cornstarch and a couple of pinches of salt. Dredge the tofu in the cornstarch mixture and transfer to a plate.
Heat a thin layer of oil in a large skillet over medium-high heat until a drop of water sprinkled on the surface splatters. Add tofu and fry until golden brown all over, about 8 minutes total. Transfer the tofu to a heatproof plate, sprinkle with salt, and keep warm in the oven.
Heat 1 tablespoon of the oil in a large skillet or wok over medium heat. Add the chiles and peanuts and stir fry until the chiles begin to char. Do not allow to blacken completely. Remove the chiles and the nuts to a small bowl and set aside.
Add the remaining 1 tablespoon oil to the skillet and increase the heat to medium high. Add the garlic and ginger and quickly stir once. Then add the broccoli, and stir-fry until tender, but still bright green, 3 to 5 minutes. Add the water chestnuts, scallions, and reserved chiles and peanuts and stir just to combine. Add the reserved cooking sauce and cook, stirring continuously, until heated through and nicely thickened. Transfer to a shallow serving bowl or platter, spoon the reserved tofu on top, and garnish with a sprinkling of chopped scallions and peanuts. Serve hot.
2011 Betsy DiJulio


text:
The Biophysical Society provides Travel Awards to the Annual Meeting for students, postdoctoral fellows, senior scientists, and international meeting attendees to recognize excellence in biophysics and promote greater interaction among biophysicists throughout the world. Specific eligibility requirements and application materials can be found here:
Minority Affairs Committee Travel Awards
Education Committee Travel Awards
International Relations Committee Travel Awards
Professional Opportunities for Women Committee Awards
The deadline for all Travel Award applications has passed.
For questions regarding Travel Awards, please visit our FAQs blog or contact the Biophysical Society at (240) 290-5600 or email@example.com.


text:
This thread is for recommending the very best amvs that primarily use non-CCS/X CLAMP anime as a source.
Please follow the rules for posting in the recommended videos forum. Any posts breaking these rules will be removed.
One post per person, please.
Videos using CLAMP (non-CCS/X)
This forum is for people to list AMVs made by others that they believe to be the best in their field.
5 posts • Page 1 of 1
- Tsunami Jones
- is the best medicine.
- Joined: Mon Oct 06, 2003 8:31 pm
- Contact:
- dj_ultima_the_great
- Joined: Mon Dec 22, 2003 7:52 pm
- Status: Resident Videogame Editor
- Location: Wisconsin
- Contact:
Everybody's favorite Angelic Layer video! This is one of those videos that manages to make you fall in love with the anime all over again. It showcases the best moments in AL, all with an upbeat, driving version of the ending theme from the anime's own OST. A must have for Angelic Layer fans.
Probably my personal favorite AL video out there. It uses an unlikely mix of music to create an action piece that captures your attention from start to finish - and it almost makes you forget that you're watching such a cutsie anime.
This is a romance video depicting the love between Chi and Hideki. It's not so overly cute or dependent on the perverted scenes like many other Chobits videos are. It also uses a good deal of effects. Just a generally solid video that's worth getting.
These two videos are both by the talented Erinn, and what they lack in video/audio quality, they make up for in quality of editing and storytelling. "Syaoran's Memories," in particular, really hashes out Syaoran's feelings about loving a girl who doesn't even remember him.
It's the must-have Kuro/Fai video for those familiar with chapters 121-127 of Tsubasa. It uses mostly manga scans to show how the relationship between the two men has been evolved in those chapters.
I can't really describe this video except to say that it has all of the wackiness that you'd expect from Watanuki. Just a fun video that will bring a smile to your face.
- Jen
- *inverse*
- Joined: Wed Aug 20, 2003 10:30 pm
- Location: BC, Canada
- Contact:
A super-cute Akira & Utako profile, from the 20-Masks arc.
(and the only solo-clamp school vid on the org)
Both are silly, well put together and a lot of fun to watch.
Last edited by *inverse* on Mon Feb 25, 2008 9:39 pm, edited 1 time in total.
- Flo'
- Joined: Sun Oct 07, 2007 1:01 pm
- Location: Vagina
- Contact:
5 posts • Page 1 of 1
Who is online
Users browsing this forum: No registered users and 0 guests


text:
By clicking 'Submit' you agree to our Terms of Use.
Step 1 - Sign Up for FREE. Sign up to singles dating Singles Warehouse by entering your email address and creating a password, or sign up with Facebook (we won't post anything to your wall don't worry). You're now on your way to date single women and single men.
Step 2 - Add a Picture. Have a picture of yourself ready to upload to your Singles Warehouse online dating profile. Profiles with pictures get much more attention than profiles without, chose a picture which clearly shows your face.
Step 3 - Complete Your Profile. Tell other singles what you are all about using our profile wizard. If you get stuck tweet us @singlewarehouse and we'll try and give you some great ideas.
Step 4 - Search for singles. Click on search and find other single men or single women with similar interests in your area. Send a free icebreaker message saying hello and watch the replies flood in!


text:
Jabra VOX Corded Stereo Wired Headsets - Retail Packaging - Black
"The Jabra Vox is Jabra's current flagship IEM. It has impressed me in many ways, but has its shortcomings. But for being only $100 MSRP, these are a definite competitor on the current market. [[SPOILER]] Package - The Vox comes in a hard-plastic container with a yellow silicone stripe down the middle, with the word, 'Vox' written on it. It feels well made, and is aesthetically pleasing to my..." --pro1137
HHI Deep Bass Vibe Earphone - Blue
Revolutionary bass and high-fashion colors combine to form a new fashion attitude. Deep Bass with unique Soft Silicon earbud naturally reduces outside noise and enables unparalleled bass levels that can actually be felt. Complete comfort is assured through unique shape soft silicon earphone cover.


text:
Main Content
This item ships within one business day.
$4.99 flat rate shipping and handling. See other shipping options.
You can never go wrong with a cute pair of shorts! The DC Wilton stretch shorts will always have you covered with adorable and comfy style. They feature three pockets and a cool DC look that will go with just about anything. They will definitely be your go-to shorts for summer!
- One back pocket
- Two front pockets
- Woven DC tag
- Stretch fabric
- 60% Cotton/39% Polyester/1% Spandex
- Metal closure and zipper fly
- Size 25 has a 2" inseam
- Imported
- Made in the USA
- Brand: DC
Special event items are produced by manufacturers only after the outcome of a game or event. These are advanced sale items and will ship immediately after they are received in our warehouse.
Manufacturer direct items are shipped directly from the manufacturer. These items are not available for international or expedited shipping.
Customized items can be personalized with options such as your name, your favorite number, and/or designs. Some options may be limited by league rules.


text:
By Ben Levisohn
Brazil's central bank took surprise action to strengthen its real. The Bovespa stock index rose 3.1%.
Mexico's inflation rate fell to 3.5% in July, down from 4.1% in June. Mexico's IPC stock index gained 1.1%.
Chile's inflation rate rose to 2.2% in July, the highest since October. The Santiago Stock Exchange IPSA Index rose 2%.
The amount of Colombian land used to grow cocaine fell by 25% in 2012.
Peru's central bank is expected to keep interest rates unchanged tonight. The Bolsa de Valores de Lima General Sector Index gained 1%.
Russia is disappointed U.S. President Barack Obama cancelled his meeting with Russian President Vladimir Putin. Russia's Micex stock index gained 0.04%
Turkey's parliament could return from its summer break to pass laws that give the nation's Kurds more rights. The Istanbul Stock Exchange National 100 Index dropped 0.7%.
Emerging Market Stocks on the Move
SouFun Holdings (SFUN) gained 13% to $38.49 after reporting better-than-forecast earnings this morning.
Companhia de Minas Buenaventura (BVN) gained 7.6% to $12.53, as gold miners rallied today.
Youku Tudou (YOKU) has dropped 5.5% to 24 in after-hours trading after reporting a loss of 10 cents a share, above forecasts for a 12 cent loss, according to Briefing.com.
OGX Petroleo e Gas (OGXPY) cancelled its meeting with analysts after the close today. Its shares rose 4.8% to 25 cents today.
China Unicom (CHU) rose 6.7% to $15.36 today after it reported a 55% increase in profits during the first half of 2013.


text:
read reviews [13]
Yields thirty-six 3-inch dumplings.
A savory pork, shrimp and salted cabbage filling, seasoned with ginger, garlic and scallions, is the most traditional filling for jiao zi. Butcher counters in Asian markets often offer several grinds of pork. For dumplings, use a coarser grind with more fat to ensure a tender, juicy filling. Hand-minced or ground beef or lamb, both typical in northern Chinese cooking, can be substituted for the ground pork and shrimp.Web extra: Watch Thy Tran's step-by-step demonstration of how to make the dumplings.
Pour the flour into a mound on a clean work surface. Make a deep, wide well in the center and pour in 1/2 cup cold water. Stir with your fingers, staying in the center at first and being careful that the water doesn't breach the wall. Little by little, using your hand and a bench knife, mix in flour from the sides until the dough starts to come together. (Alternatively, put the flour in a medium bowl. Make a well, add the water, and stir first with a spoon and then your hand.) If the dough remains in shreds, sprinkle in additional water, a teaspoon at a time, until it begins to stick together. Don't add too much water or the dough will be difficult to work.
Knead the dough for 5 minutes to form a smooth, firm, elastic ball. (If you began the dough in a bowl, lightly dust a clean, dry surface with flour before kneading.) The dough should not be sticky and should bounce back when pressed with a fingertip. Divide in half with a bench knife and roll into two 6-inch logs. Sprinkle each log evenly with flour, cover with a clean kitchen towel, and let rest for at least 30 minutes at room temperature before rolling and filling.
In a medium bowl, toss the cabbage with 2 tsp. salt and set aside for 30 minutes to shed moisture. Wring out in a clean kitchen towel to extract as much liquid as possible.
In a large bowl, combine the cabbage with the pork, shrimp, scallions, garlic, Shaoxing, ginger, soy sauce, sesame oil, sugar, and 1/4 tsp. pepper. Stir until well mixed. Refrigerate for at least 20 minutes.
Cut each log in half crosswise. Cut each half crosswise into thirds, and then slice each of those pieces into three even coins. You should have 36 pieces of equal size. Toss the pieces in flour to coat evenly and then cover with a clean towel so they don't dry out.
Using a small rolling pin, roll a piece of dough into a thin 3-inch circle; with the dough in one hand and the pin in the other, roll from the edges toward the center as you rotate the dough. This rolling technique helps create a round with thin edges and a thicker center.
Spoon 1 to 2 tsp. of the filling onto a dough circle, fold it in half, and then if you're going to boil the dumplings, seal it by pinching along the curved edge. If you're planning to pan-fry the dumplings for pot stickers, make your first pinch at the center of the curved edge and then pleat toward the center on both sides to create a rounded belly. This wider shape allows the dumplings to sit upright in the pan and form a flat surface for browning.
Repeat with the remaining wrappers and filling. As you work, arrange the filled dumplings in a single layer without touching on large plates, so they don't stick together.
Bring a large (7- to 8-quart) pot of salted water to a boil. Working in 2 or 3 batches to avoid overcrowding, quickly add the dumplings one at a time, making sure they don't stick to each other. Lower the heat to medium and continue to boil, gently stirring occasionally, until the dumplings float and are cooked through, 3 to 5 minutes. Remove with a slotted spoon and serve immediately with your choice of dipping sauce.
Heat 2 Tbs. vegetable oil in a heavy-duty 10- or 12-inch skillet over medium-high heat until shimmering. Working quickly and in batches if necessary (adding more oil for the second batch if needed), arrange the dumplings belly side down in concentric circles starting from the outer edge. Cook until golden brown on the bottom, 1 to 2 minutes. Pour in about 1/2 cup water or enough to come about a third of the way up the sides of the dumplings, bring to a boil, cover, and cook until all of the water has been absorbed, 2 to 3 minutes. Remove the lid, reduce the heat to medium, and continue cooking just until the dumplings are dry and crisp on the bottom, 1 to 2 minutes. Loosen the dumplings from the pan with a spatula. Invert the pan over a plate to flip the dumplings, browned side up, onto the plate (or transfer with a spatula). Serve immediately with your choice of dipping sauce,.
The dough can be covered with plastic and refrigerated for up to 8 hours. If refrigerated, return to room temperature before rolling. The filling can also be made up to 8 hours ahead and refrigerated. Filled, shaped dumplings may be covered and refrigerated for up to 4 hours or frozen for up to three months. To freeze, arrange just-formed dumplings in a single layer on lightly floured baking sheets and freeze for at least four hours. Once they are frozen through, tranfer the dumplings to freezer storage bags. The dumplings can be boiled or pan-fried directly from the freezer; simply increase the cooking time by three to four minutes.
nutrition information (per serving):
per dumpling, Calories
60, Fat
3, Fat Calories
30, Saturated Fat
1, Protein
3, Monounsaturated Fat
1.5, Carbohydrates
5, Polyunsaturated Fat
0.5, Sodium
85, Cholesterol
15, Fiber
Photo: Scott Phillips
FineCooking.com is a part of the Taunton Home and Garden Network
Taunton Home |
Books & Videos |
Contact Us |
Product recall information
Privacy Policy |
Copyright Notice |
Taunton Guarantee |
User Agreement |
About Us |
Work for Us |
Contact Us |
Advertise |
Customer Service
© 2017 The Taunton Press, Inc., Part of Taunton's Women's Network. All rights reserved.


text:
NEW: The US Department of State has announced that that Embassies and Consulates are able to issue first time student visas 120 days or less, in advance of the course of study registration date. While you may apply for a visa more than 120 days prior to your start date or registration date as provided on the Form I-20, the Embassy or Consulate will hold your application until it is able to issue the visa. You may enter the US no more than 30 days in advance of your start date.
The US Department of State has an excellent website that outlines the process of obtaining a student visa for studying in the USA.
To enter the United States with your Form I-20 (F-1 students) or your Form DS-2019 (J-1 students) and attend Muskingum College, you must make an appointment at the nearest United States embassy or consulate and apply for a visa. In order to find the US Embassy or Consulate that is most convenient for you, please click here.
SEVIS Fee
As of September 1, 2004 the U.S. Department of Homeland Security requires that each new student issued an initial I-20 or DS-2019 pay a $100 SEVIS fee before his or her consular interview. You can only pay this SEVIS fee after the initial I-20/DS-2019 has been issued by the school you wish to attend. FORM I-901 is used to pay the SEVIS fee and is available online.
The two easiest ways to pay are online at www.FMJfee.com or by Western Union Quick Pay service. If you use the FMJFee website, please be sure to have a printer ready, since you will have only one opportunity to print the receipt. You may also pay with a check or bank draft drawn on a U.S. bank sent via mail or courier with your completed Form I-901. This method is acceptable, but is not recommended since it may take up to a month for processing. If you are transferring schools, extending your program, applying for an F-2 dependent visa, or have paid this fee and been denied a visa within the last twelve months, you do not need to pay the $100 SEVIS fee. The SEVIS fee receipt must be taken to the consulate interview and border crossing. To download the form or for more information on the SEVIS fee, please visit the US Customs and Immigration website.
Effective June 30, 2006, telephone number for international I-901 SEVIS fee customers will be +1 (212) 620-3418. International Students and Exchange Visitors may call the toll-free number for all questions regarding the I-901 SEVIS fee that cannot be answered after viewing the information available at http://www.ice.gov/sevis/i901/index.htm.
Please note that the toll-free number is for international callers only and is available during the following business hours: Monday-Friday, 8:00 a.m. until 8:00 p.m. Eastern Standard Time.
How do I apply for a visa?
Before you apply for the visa, you should understand the process and the rules governing visas. Many visa applications fail. Often it is because the student did not know the rules or was not prepared. We do not want this to happen to you, so please read the following information carefully and contact us if you have any questions.
Understanding the rules for US visa applications
The first rule may seem strange to you. The consular officer who makes the decision on your visa application is required to think of you as someone who plans to come to the U.S. permanently and YOU must prove that you intend to return to your home country after completing your studies. U.S. law clearly states that F and J visas may be given only to persons who intend to remain in the United States temporarily. Not meeting this rule is the number one reason for denials of visa applications.
The other important rules are:
U.S. government officials are much more easily convinced by documents than by spoken statements. When possible, have papers to show your connections to your home country. The consular officer will take a very impersonal view on administering U.S. laws. This may be considered rude in many countries, but not in the U.S., where the ideal is to apply laws equally to all regardless of status or gender. Do not try to negotiate with the officer or discuss personal matters.
Be prepared
Citizens of Canada and the British Overseas Territory of Bermuda
Canadian citizens are not required to have a U.S. visa to enter the United States. You must present your I-20 (or DS-2019) form, your SEVIS fee receipt, and proof of financial support at the U.S. port of entry. The INS inspector will stamp your I-20 (or DS-2019) and issue you an I-94 card that indicates that you are in F-1 (or J-1) status. It is critical that you enter the U.S. in student status to be eligible for the benefits of that status, including on-campus work permission, optional practical training etc. If you enter the U.S. without any documentation, you are assumed to be in tourist/visitor status and are not entitled to these benefits.
Your spouse and children may apply for visas with you or they may apply to join you after you come to the U.S., but only if they are mentioned on your Form I-20 or DS-2019. You will also need to demonstrate financial support for each of your dependents.
If your visa application is denied
If you are denied a student visa, do not try to argue with the consular officer. Politely ask the officer for a list of documents you should bring in order to overcome the refusal, and try to get in writing the reason you were denied. Notify us with complete details of everything that was said at your interview. If possible, tell us the name of the consular officer and send a copy of any written answer you may receive.
Helpful Internet websites
The following websites offer advice and instructions when applying for non-immigrant visas:
Maps & Directions
Academic Affairs
Undergraduate Admission
Financial Aid
Graduate & Continuing Studies
Business Office
Academic Catalogs


text:
- Home
- Search for Research Summaries, Reviews, and Reports
EHC Component
- EPC Project
Topic Title
- Off-Label Use of Atypical Antipsychotics: An Update
Full Report
- Research Review (Update) Sept. 27, 2011
Related Products for this Topic
- Research Protocol May 19, 2010
- Surveillance Report (Update) Jul. 5, 2016
Journal Publications
Prior Reports
Original Nomination
Executive Summary – Sept. 27, 2011
Off-Label Use of Atypical Antipsychotics: An Update
- View PDF (PDF) 126 kB
- Help with Viewers, Players, and Plug-ins
Partly out of date: This report was assessed in May 2016 and some conclusions may not be current.
Table of Contents
Antipsychotics medications are approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia and bipolar disorder. These medications are commonly divided into two classes, reflecting two waves of historical development: the conventional antipsychotics and the atypical. The conventional antipsychotics served as the first successful pharmacologic treatment for primary psychotic disorders such as schizophrenia. Having been widely used for decades, the conventional antipsychotics also produced various side effects requiring additional medications, which spurred the development of the atypical antipsychotics.
Currently, nine atypical antipsychotic drugs have been approved by FDA: aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone. These drugs have been used off-label (i.e., for indications not approved by FDA) for the treatment of various psychiatric conditions. While it is legal for a physician to prescribe drugs in such a manner, it is illegal for the manufacturer to actively promote such use.
A 2006 study on Efficacy and Comparative Effectiveness of Off-label Use of Atypical Antipsychotics reviewed the scientific evidence on the safety, efficacy, and effectiveness for off-label uses. (Clozapine was excluded because of its association with a potentially fatal blood disorder of bone marrow suppression, and it requires frequent blood tests for safety monitoring.) The 2006 study examined 84 published studies on atypicals and found that the most common off-label uses of the drugs were for treatment of depression, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), personality disorders, Tourette's syndrome, autism, and agitation in dementia. It concluded that with few exceptions, there was insufficient high-strength evidence to reach conclusions about the efficacy of any off-label uses of these medications. It also found strong evidence that atypicals are associated with increased risk of adverse events such as significant weight gain, sedation, and, among the elderly, increased mortality. Future research areas suggested by the report include safe treatment for agitation in dementia, association between the increased risk of death and antipsychotics drugs, and comparison of the development of adverse effects between patients taking atypical antipsychotics and those taking conventional antipsychotics.
Since publication of that report, important changes have occurred that make the report out of date. Studies have been published on new off-label uses, such as treatment of eating disorders, insomnia, attention-deficit hyperactivity disorder (ADHD), anxiety, and substance abuse. New or increased adverse effects of off-label indications have been observed and new atypicals (asenapine, iloperidone, and paliperidone) have been approved by FDA for the treatment of schizophrenia and bipolar disorder. In addition, the following previously off-label uses have been approved for on-label use by the FDA:
- Quetiapine and quetiapine ER (extended release) as monotherapy in bipolar depression
- Quetiapine ER as augmentation for major depressive disorder (MDD)
- Aripiprazole as augmentation for MDD
- Olanzapine/fluoxetine combination for MDD
- Olanzapine/fluoxetine combination for bipolar depression
- Risperidone and aripiprazole for autism spectrum disorders
An update is needed to better understand the trends in off-label use and the associated risks and benefits. Further, a number of issues remain unclear due to insufficient information in the previous report: subpopulations (i.e., race/ethnicity, gender) that would benefit most from atypical antipsychotics, appropriate dose, and time needed to see clinical improvement. This update will try to address these issues.
This report covers the following off-label uses of atypical antipsychotic medications: anxiety, ADHD, dementia and severe geriatric agitation, major depressive disorder (MDD), eating disorders, insomnia, OCD, PTSD, personality disorders, substance abuse, and Tourette's syndrome. Autism, included in the original systematic review, is now reviewed in a study on the comparative effectiveness of typical and atypical antipsychotics for on-label indications, conducted by another organization.
This report addresses the following Key Questions:
- Key Question 1: What are the leading off-label uses of atypical antipsychotics in utilization studies? How have trends in utilization changed in recent years, including inpatient versus outpatient use? What new uses are being studied in trials?
- Key Question 2: What does the evidence show regarding the efficacy and comparative effectiveness of atypical antipsychotics for off-label indications?
- Sub-Key Question 2: How do atypical antipsychotic medications compare with other drugs, including first-generation antipsychotics, for treating off-label indications?
- Key Question 3: What subset of the population would potentially benefit from off-label uses? Do effectiveness and harms differ by race/ethnicity, gender, and age group? By severity of condition and clinical subtype?
- Key Question 4: What are the potential adverse effects and/or complications involved with off-label prescribing of atypical antipsychotics? How do they compare within the class and with other drugs used for the conditions?
- Key Question 5: What is the effective dose and time limit for off-label indications?
Key Question 1: What are the leading off-label uses of atypical antipsychotics in utilization studies? How have trends in utilization changed in recent years, including inpatient versus outpatient use? What new uses are being studied in trials?
- Atypicals have been studied as off-label treatment for the following conditions: ADHD, anxiety, dementia in elderly patients, depression, eating disorders, insomnia, OCD, personality disorder, PTSD, substance use disorders, and Tourette's syndrome.
- Off-label use of atypical antipsychotics in various settings has increased rapidly since their introduction in the 1990s; risperidone, quetiapine, and olanzapine are the most common atypicals prescribed for off-label use.
- One recent study indicated that the 2005 regulatory warning from the FDA and Health Canada was associated with decreases in the overall use of atypical antipsychotics, especially among elderly dementia patients.
- Use of atypicals in the elderly is much higher in long-term care settings than in the community.
- Atypicals are frequently prescribed to treat PTSD in the U.S. Department of Veterans Affairs health system.At least 90 percent of antipsychotics prescribed to children are atypical, rather than conventional antipsychotics. The majority of use is off-label.
- No off-label use of the newly approved atypicals (asenapine, iloperidone, and paliperidone) was reported in the utilization literature.
Key Question 2: What does the evidence show regarding the efficacy and comparative effectiveness of atypical antipsychotics, for off-label indications? Sub-Key Question 2: How do atypical antipsychotic medications compare with other drugs, including first-generation antipsychotics, for treating off-label indications?
The efficacy results are summarized in Table A below. It is important to note that no trials of the three most recently FDA-approved atypicals (asenapine, iloperidone, and paliperidone) were found for off-label use. Cells shaded in green indicate areas with the strongest evidence of efficacy, followed by the areas in blue. White areas containing circles indicate areas where no clinical trials exist. Brown and pink areas indicate areas where evidence of inefficacy exists.
Table A. Summary of strength of evidence of efficacy, by drug and condition
++ moderate or high evidence of efficacy
MDD = major depressive disorder; SSRI = selective serotonin reuptake inhibitor; SNRI = serotonin-norepinephrine reuptake inhibitors
Note: Symbols denote strength of evidence, not size of portential effect. For example in dementia "++" indicates moderate-to-high strength of evidence that there is a beneficial effect, however the size of the effect is small.
|generalized anxiety disorder
|social phobia
|Attention Deficit/Hyperactivity Disorder
|no co-occurring disorders
|bipolar children
|mentally retarded children
|MDD augmentation of SSRI/SNRI
|MDD: Monotherapy
|Eating Disorders
|Obsessive Compulsive Disorder
|augmentation of SSRI
|augmentation of citalopram
|Personality Disorder
|Post Traumatic Stress Disorder
|Substance Abuse
|methadone clients
|Tourette's Syndrome
Table B below shows how our current efficacy findings compare with those of our original Comparative Effectiveness Review (CER) submitted to the Agency for Healthcare Research and Quality (AHRQ) in 2006. The evidence that atypicals have efficacy in treating symptoms of dementia has increased in the past few years; this evidence must be weighed against possible harms described in Key Question 4 below. Evidence of efficacy as augmentation for MDD and OCD patients who have not responded adequately to selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors (SSRIs/SNRIs) has also increased. Table B is organized as follows: First, all conditions dealt with in our original CER, in alphabetical order; second, all the new off-label indications in alphabetical order.
|Strength of Evidence
|2006 Findings
|2011 Findings
|2011 Conclusions
|ADHD = attention-deficit hyperactivity disorder; BEHAVE-AD = Behavioral Pathology in Alzheimer's Disease Scale; BPRS = Brief Psychiatric Rating Scale; CGI-BPD = Clinical Global Impression Scale for Borderline Personality Disorder; CGI-I = Clinical Global Impression Improvement; CGI-S = Clinical Global Impression-Severity; CMAI = Cohen-Mansfield Agitation Inventory; HAM-A = Hamilton Anxiety Scale; HAM-D = Hamilton Depression Rating Scale; MADRS = Montgomery-Asberg Depression Rating Scale; MDD = major depressive disorder; NPI = Neuropsychiatric Inventory; OCD = obsessive-compulsive disorder; PANSS = Positive and Negative Syndrome Scale; PCT = placebo-controlled trial; PTSD = post-traumatic stress disorder; SSRI = selective serotonin reuptake inhibitor; SNRI = serotonin-norepinephrine reuptake inhibitors; ZAN-BPD = Zanarini Rating Scale for Borderline Personality Disorder
A published meta-analysis of 15 placebo-controlled trials (PCTs) found small but statistically significant effects favoring treatment with risperidone and aripiprazole.
Overall – In our meta-analysis of PCTs, aripiprazole, olanzapine, and risperidone were superior to placebo as treatment of behavioral symptoms as measured by total scores on BEHAVE-AD, BPRS, and NPI. Effect sizes were generally considered to be "small" in magnitude.
|Aripiprazole, olanzapine, and risperidone have efficacy as treatment for behavioral symptoms of dementia.
|Depression – MDD: augmentation of SSRI/SNRI
Moderate: risperidone, aripiprazole, quetiapine
Three trials assessed the combination of olanzapine and fluoxetine, one trial each assessed augmentation of various SRIs with risperidone, ziprasidone, and quetiapine, and one study assessed adding risperidone versus olanzapine to SSRI.
We conducted a meta-analysis using "response" to treatment and remission as outcome. Pooling trials that reported the HAM-D as outcome, the relative risk of responding for participants taking quetiapine or risperidone was significantly higher than for placebo. Olanzapine had only two trials, so pooling was not performed; the trials reported olanzapine superior to placebo. Other trials reported MADRS scores; the relative risk of responding for participants taking aripiprazole was significantly higher than those taking placebo. Risperidone and ziprasidone were included in two trials and one trial, respectively. These reported the drug superior to placebo.
|Aripiprazole, quetiapine, and risperidone have efficacy as augmentation to SSRIs/SNRIs for major depressive disorder. Olanzapine and ziprasidone may also have efficacy.
|Depression – MDD: Monotherapy
|The three olanzapine studies (above) also assessed its efficacy as monotherapy. Olanzapine alone was no better than placebo in improving symptoms at 6 or 12 weeks. Outcomes were too heterogeneous to allow pooling.
|In our meta-analysis of five placebo-controlled trials, quetiapine was superior according to relative risk of both responding and remitted as measured by MADRS.
Olanzapine does not have efficacy as monotherapy for major depressive disorder.
|Obsessive-compulsive disorder – augmentation of SSRI
Moderate: risperidone
|12 trials used risperidone, olanzapine, or quetiapine as augmentation therapy in patients who were resistant to treatment with SSRI. Nine trials were sufficiently similar clinically to pool. Atypical antipsychotics had a clinically important benefit (measured by the Yale-Brown Obsessive-Compulsive Scale) when used as augmentation therapy. Relative risk of "responding" significant for augmentation with quetiapine and risperidone. There were too few studies of olanzapine augmentation to permit separate pooling of this drug.
Our updated meta-analysis found risperidone superior to placebo, as measured by changed in the Yale Brown Obsessive Compulsive Scale (Y-BOCS). There were too few studies (two) to permit separate pooling for olanzapine; both trials reported olanzapine superior to placebo.
Risperidone has efficacy in improving OCD symptoms when used as an adjunct to SSRI in treatment refractory patients. Olanzapine may also have efficacy.
|Obsessive-compulsive disorder – augmentation of citalopram
Low: quetiapine
|One trial of risperidone reported no differences between groups in achieving a response to therapy, but patients maintained on risperidone had a significantly longer period of time to relapse compared to placebo (102 days vs. 85 days).
|Two new trials found quetiapine superior to placebo as augmentation for citalopram, according to Y-BOCS and CGI-I scores.
|Quetiapine and risperidone may be efficacious as augmentation to citalopram in OCD patients.
|Post-traumatic stress disorder
Moderate: risperidone
|Four trials of risperidone and two trials of olanzapine, each of at least 6 week duration, treated patients with PTSD. Three trials enrolled men with combat-related PTSD; these showed a benefit in sleep quality, depression, anxiety, and overall symptoms when risperidone or olanzapine was used to augment therapy with antidepressants or other psychotropic medication. Three trials of olanzapine or risperidone as monotherapy for abused women with PTSD were inconclusive regarding efficacy.
Three new trials of risperidone were found, allowing us to conduct a meta-analysis using the Clinician Administered PTSD Scale (CAPS) as outcome. Risperidone was superior to placebo. There were too few olanzapine studies (two) to pool; one reported olanzapine superior to placebo, while one did not.
|Risperidone is efficacious in reducing combat-related PTSD symptoms when used as an adjunct to primary medication.
|Personality disorders – borderline
Low: aripiprazole
|Three trials provide evidence that olanzapine is superior to placebo and may be superior to fluoxetine. The benefit of adding olanzapine to dialectical therapy in one trial was small. Aripiprazole was superior to placebo in one small trial.
|One new trial found aripiprazole superior to placebo in improving SCL-90, HAM-D, and HAM-A scores at 8 months and less self-injury at 18 months. One new trial of ziprasidone found no significant difference in CGI-BPD, depressive, anxiety, psychotic or impulsive symptoms compared to placebo at 12 weeks. Two new trials of olanzapine found no difference from placebo in any outcomes, while another new trial of olanzapine found greater change in ZAN-BPD scores at 12 weeks, compared with placebo. One new trial found quetiapine superior to placebo on BPRS, PANSS scales. Due to heterogeneity of outcomes, we could not perform a meta-analysis.
|Olanzapine had mixed results in 7 trials, aripiprazole was found efficacious in two trials, quetiapine was found efficacious in one trial, and ziprasidone was found not efficacious in one trial.
|Personality disorders – schizotypal
|Risperidone was superior to placebo in one small trial.
|One new small trial of risperidone found no difference from placebo on a cognitive assessment battery.
|Risperidone had mixed results when used to treat schizotypal personality disorder in two small trials.
|Tourette's syndrome
|Risperidone was superior to placebo in one small trial, and it was at least as effective as pimozide or clonidine for 8 to 12 weeks of therapy in the three other trials. One trial of ziprasidone showed variable efficacy compared to placebo.
|No additional trials.
|Same as 2006: Risperidone is at least as efficacious as pimozide or clonidine for Tourette's syndrome.
|Not covered.
Three placebo-controlled trials of quetiapine as monotherapy for Generalized Anxiety Disorder (GAD) could be pooled; relative risk of responding on HAM-A favored the quetiapine group.
|Quetiapine has efficacy as treatment for Generalized Anxiety Disorder
|Attention deficit/ hyperactivity disorder – no co-occurring disorders
|Not covered.
|One trial showed risperidone superior to placebo in reducing scores on the Children's Aggression Scale – Parent version (CAS-P).
|Risperidone may be efficacious in treating children with ADHD with no serious co-occurring disorders.
|Attention deficit/ hyperactivity disorder – mentally retarded children
|Not covered.
|One trial showed risperidone led to greater reduction in SNAP-IV (Swanson, Nolan, and Pelham teacher & parent rating scale) scores than methylphenidate.
|Risperidone may be superior to methylphenidate in treating ADHD symptoms in mentally retarded children.
|Attention deficit/ hyperactivity disorder – bipolar children
|Not covered.
|Two trials of aripiprazole showed no effect on SNAP-IV (Swanson, Nolan, and Pelham teacher & parent rating scale) scores than placebo.
|Aripiprazole is inefficacious in reducing ADHD symptoms in children with bipolar disorder.
|Eating disorders
Moderate: olanzapine
|Not covered.
Five trials of olanzapine were found; three reporting Body Mass Index (BMI) could be pooled. There was no difference in change in BMI at either one or three months compared to placebo.
|Olanzapine and quetiapine have no efficacy in increasing body mass in eating disorder patients.
|Very low
|Not covered.
|In one small trial (N=13) of quetiapine, sleep outcomes were not statistically different from placebo.
|Quetiapine may be inefficacious in treating insomnia.
|Substance abuse – alcohol
Moderate: aripiprazole
|Not covered.
|Two trials of aripiprazole and one of quetiapine reported % of patients completely abstinent during follow-up. In our pooled analysis, the effect versus placebo was insignificant.
|Aripiprazole is inefficacious in treating alcohol abuse /dependence. Quetiapine may also be inefficacious.
|Substance abuse – cocaine
|Not covered.
|Two trials of olanzapine and one of risperidone reported there was no difference in efficacy versus placebo as measured by the Addiction Severity Index (ASI).
|Olanzapine is inefficacious in treating cocaine abuse /dependence. Risperidone may also be inefficacious.
|Substance abuse – meth-amphetamine
|Not covered.
|One trial found aripiprazole inefficacious in reducing use of intravenous amphetamine, as measured by urinalysis. Another trial found aripiprazole inefficacious in reducing craving for methamphetamine.
|Aripiprazole is inefficacious in treating methamphetamine abuse/dependence.
|Substance abuse – methadone clients
|Not covered.
|One trial of methadone clients found no difference between risperidone and placebo in reduction of cocaine or heroin use.
|Risperidone is an inefficacious adjunct to methadone maintenance.
Key Question 3: What subset of the population would potentially benefit from off-label uses? Do effectiveness and harms differ by race/ethnicity, gender, and age group? By severity of condition and clinical subtype?
There are insufficient data regarding efficacy, effectiveness, and harms to determine what subset of the population would potentially benefit from off-label uses of atypicals. Only one study conducted a subgroup analysis by gender; there were no studies that stratified by racial or ethnic group. Although many studies specified age in their inclusion criteria, few studies stratified results by age.
Examination of the literature for differing efficacy of atypicals by clinical subsets did not reveal studies reporting subgroup analyses. Our own meta-analysis found efficacy for combat-related PTSD in men but not for PTSD in civilian women, although these data come from separate literatures, and head-to-head comparison of gender effects within study have not been performed. Due to the varying measures utilized in determining severity of illness, it was not possible to analyze treatment effects by severity of illness across any other condition.
Key Question 4: What are the potential adverse effects and/or complications involved with off-label prescribing of atypical antipsychotics? How do they compare within the class and with other drugs used for the conditions?
Table C compares the most important findings regarding adverse events, by age group and study design.
|Adverse Event
|Head-to-Head Comparisons
|Active Comparisons
|Placebo Comparisons
|BMI = body mass index; CATIE-AD = Clinical Antipsychotic Trials of Intervention Effectiveness-Alzheimer's Disease; CVA = cerebrovascular accident; EPS = extrapyramidal symptoms; PCT = placebo-controlled trial; SSRI = serotonin selective reuptake inhibitor
|Weight gain – Elderly patients
|In one large trial (CATIE-AD) patients who were treated with olanzapine, quetiapine, or risperidone averaged a monthly gain of 1.0, 0.7, and 0.4 lbs respectively, compared with a monthly weight loss of 0.9 lbs for placebo patients.
|More common in patients taking olanzapine than risperidone or conventional antipsychotics, particularly if their BMI was less than 25 at baseline, according to a large cohort study.
|More common in patients taking olanzapine and risperidone than placebo according to our meta-analysis.
|Weight gain – Adults 18–64
|More common in olanzapine patients than ziprasidone patients in one trial.
More common among patients taking olanzapine than patients taking conventional antipsychotics in three trials.
|More common in patients taking aripiprazole, olanzapine, quetiapine, and risperidone than placebo according to our meta-analysis.
|Weight gain – Children & adolescents
|No head-to-head studies
|No difference between clonidine and risperidone in one trial.
|More common in patients taking risperidone in two PCTs. No difference in one small PCT of ziprasidone.
|Mortality – Elderly patients
|No difference between olanzapine and risperidone according to a meta-analysis of six trials of olanzapine published in 2006.
|Six large cohort studies compared mortality in elderly patients taking atypical and conventional antipsychotics. Four of these studies found a significantly higher rate of death with conventional antipsychotics, while two found no statistical difference in mortality between the drug classes.
The difference in risk for death was small but statistically significant for atypicals, according to a 2006 meta-analysis which remains the best available estimate. Sensitivity analyses found no difference between drugs in the class.
|Endocrine/ diabetes – Elderly patients
|No evidence reported.
|No evidence reported.
No difference in endocrine events in risperidone patients in one PCT.
|Endocrine/ diabetes – Adults 18–64
|Diabetes more common in patients taking olanzapine than patients taking risperidone in one trial.
|No evidence reported.
Endocrine events more common in patients taking quetiapine, risperidone, and ziprasidone in one PCT each. More common in olanzapine in two pooled PCTs.
|CVA – Elderly patients
|No evidence reported.
|Hospitalization for CVA was increased in the first week after initiation of conventional antipsychotics, but not for initiation of atypicals in a large cohort study.
More common in risperidone patients than placebo according to four PCTs pooled by the manufacturer. In our new meta-analysis of PCTs, risperidone was the only drug associated with an increase.
|EPS – Elderly patients
|More common in patients taking aripiprazole and risperidone patients than patients taking quetiapine in one large trial (CATIE-AD).
|No evidence reported.
More common in patients taking risperidone, according to our meta-analysis. Quetiapine and aripiprazole were not associated with an increase.
|EPS – Adults 18–64
|No evidence reported
Less likely in patients taking quetiapine than mood stabilizers in one small trial.
|More common in patients taking aripiprazole, quetiapine, and ziprasidone than placebo according to our meta-analysis.
|Sedation – Elderly patients
|More common in elderly patients taking olanzapine or quetiapine than risperidone according to our analysis, but not quite statistically significant.
No difference in one trial of olanzapine versus benzodiazepines.
|More common in patients taking aripiprazole, olanzapine, quetiapine, and risperidone than placebo according to our meta-analysis.
|Sedation – Children and adolescents
|No head-to-head trials.
|No difference in one small trial of clonidine versus risperidone. More patients on haloperidol than risperidone reported sleep problems in one trial.
|Less common in aripiprazole patients than placebo patients in one PCT. No difference from placebo in one small PCT of ziprasidone.
|Sedation – Adults 18–64
More common in patients taking quetiapine than risperidone in two trials.
Olanzapine patients had higher odds than mood stabilizer patients in two trials.
|More common in patients taking aripiprazole, olanzapine, quetiapine, risperidone, and ziprasidone than placebo in our meta-analysis.
Key Question 5: What is the effective dose and time limit for off-label indications?
There are too few studies comparing doses of atypical antipsychotic medications to draw a conclusion about a minimum dose needed. Most trials used flexible dosing, resulting in patients taking a wide range of doses. According to a meta-analysis we were able to conduct using the percentage of remitters and responders according to the MADRS as outcome, 150 mg quetiapine daily augmentation has equal efficacy as augmentation with 300 mg for patients with MDD who respond inadequately to SSRIs. More trials examining different doses of other atypicals for MDD would help guide clinicians in treating this population. In addition, more dosage trials for treating conditions such as OCD, PTSD, and anxiety disorder would allow for pooling and comparison of results.
Though there is some trial data regarding duration of treatment in PTSD, eating disorders, and borderline personality disorder, the outcome of treatment appears to be the same regardless of reported followup time.
Remaining Issues
The overarching finding of this review is that although atypical antipsychotic medications are used for a large number of off-label indications, there is moderate to strong evidence of efficacy for only a few of the drugs and for only a few of the off-label indications. Most of the evidence is for the drugs risperidone, olanzapine, and quetiapine, for the off-label indications of dementia, depression, and OCD. For the newly approved atypicals (asenapine, iloperidone, and paliperidone), we found no clinical trials assessing their use for any off-label condition, and for some off-label uses, we found no or only a small number of trials. Head-to-head comparisons of atypical antipsychotic drugs for off-label uses are few, and evidence from placebo-controlled trials for off-label use suggests that efficacy differs between drugs, meaning that the assumption of a "class effect" for atypical antipsychotics may be unwarranted. This means that each drug requires its own evaluation of efficacy for each off-label indication, which is a large task; drugs demonstrated to be efficacious will need to be compared in head-to-head in trials.
There is almost no evidence about how treatment efficacy may vary within populations, including variations due to gender, race, ethnicity, or medical comorbidities. In addition, existing evidence about the role of baseline severity of disease is too heterogeneous to allow us to draw conclusions. In future research, standardized measures of disease severity might allow for greater knowledge of the patient populations who would benefit from treatment with atypical agents.
Regarding adverse effects of the atypical antipsychotics, existing evidence varies by drug and by description of the adverse event. It would facilitate assessments of comparative effectiveness if future studies contained a standardized list of assessed side effects. As many trials report only those side effects observed, we are unable to compare between trials for many of the side effects.
Another area where clinical guidance is needed is in the dosages required to achieve effects in off-label indications. The dosages used in off-label indications varied from those used in on-label indications. There were few trials that compared effects by dose. Most studies used "flexible" dosing, where a patients dosage can be adjusted during the trial. Thus, a dosage comparison across trials was generally not possible. More research, examining differing dosages within the same population, is required in order to guide clinicians in the appropriate doses to prescribe. A similar issue is that of treatment length. More research reporting responses at various time points would be helpful in determining how long treatment is required. Given the risk of side effects when using these agents, clinicians need to know when a result is expected to prevent continuing an inefficacious agent, unnecessarily.
Newer agents, such as asenapine, iloperidone, and paliperidone, cannot be assumed to have efficacy and harms similar to the older atypical antipsychotics, since the evidence to date does not support that there is a general "class effect" in terms of either efficacy or harm for most off-label indications. Trials assessing the newer agents' efficacy and safety are necessary if they are to be used off-label for any of the above treatment areas.
Full Report
This executive summary is part of the following document: Maglione M, Ruelaz Maher A, Hu J, Wang Z, Shanman R, Shekelle PG, Roth B, Hilton L, Suttorp MJ, Ewing BA, Motala A, Perry T. Off-Label Use of Atypical Antipsychotics: An Update. Comparative Effectiveness Review No. 43. (Prepared by the Southern California/RAND Evidence-based Practice Center under Contract No. HHSA290-2007-10062-1.) AHRQ Publication No. 11-EHC087-EF. Rockville, MD: Agency for Healthcare Research and Quality. September 2011. www.effectivehealthcare.ahrq.gov/reports/final.cfm.
For More Copies
For more copies of Off-Label Use of Atypical Antipsychotics: An Update: Executive Summary No. 43 (AHRQ Pub. No 11-EHC087-1), please call the AHRQ Clearinghouse at 1-800-358-9295 or email firstname.lastname@example.com.


text:
Scrabble words containing "LAXLY"
Scrabble Words that contain: LAXLY
More about "LAXLY"
SCRABBLE is the registered trademark of Hasbro and J.W. Spear & Sons Limited. Our scrabble word finder and scrabble cheat word builder is not associated with the Scrabble brand - we merely provide help for players of the official Scrabble game. All intellectual property rights to the game are owned by respective owners in the U.S.A and Canada and the rest of the world. Anagrammer.com is not affiliated with Scrabble. This site is an educational tool and resource for Scrabble & Words With Friends players.


text:
Contact Information
You can email us at webmaster at perl.org.
About the website
The website is run as part of the Perl.org infrastructure, our center of operations is The Perl NOC. You can track our progress at the Perl NOC Log.
Privacy Policy
We do not collect any personal data at this time, but if we do, you'll find the privacy policy here.
Copyright © 2002-2017 Perl.org unless otherwise specified.
Intellectual Property
The use of the camel image in association with the Perl language is a trademark of O'Reilly Media, Inc. Used with permission.
www.perl.org is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.
Related sites


text:
CE Courses
Implant Dentistry: Avoiding and Solving Complications
Saturday, May 18, 2013
Anthony Neely, DDS, MDentSc, PhD
Course Overview
This one-day implant course emphasizes the sound decision making process that will help the general practitioner avoid complications during implant therapy. Issues in implant placement from a surgical point of view will be presented. Soft and hard tissue evaluation and assessment will be presented in a logical manner that helps practitioners aim for optimal functional and esthetic outcomes.
The hands-on component of this course will teach participants how to make impressions and surgical guides in their office. Appropriate implant and abutment selection will be presented as well as indications for different prosthetic restorations (i.e. screw versus cement retained) to the participants.
This course presents treatment planning for partially-edentulous patients for implant-supported restorations. Participants are encouraged to bring their cases from private practice for discussion.
Course Objectives
At the completion of the course participants will be able to:
- Identify and avoid common soft and hard tissue complications
- Identify prosthetic problems before they arise
- Fabricate a surgical guide in office
- Make impression for implant-supported restorations
- Understand delivery of implant-supported restorations
- Identify alternative solutions to simple and complex implant cases
- Treatment plan for single and advanced partially edentulous implant cases
University of Detroit Mercy Dental Corktown Campus, Detroit, MI
Click here for directions
Tuition includes continental breakfast and lunch.
Dentists - $275; Allied - $150
UDM Alumni: Dentists - $247.50; Allied - $135
If you choose to pay for a continuing education course by check, please note that the check must be received by UDM within ten (10) days of registration. If the check is not received within ten (10) days of registration, we will assume that you are no longer interested in the course and will remove you from the course roster and you will forfeit your held seat. If you register less than ten (10) days prior to the start of a course, payment will be accepted up to the course start time. If additional time is required, please contact 313-494-6626 prior to registering to make a payment arrangement.
9:00 AM to 4:00 PM; Registration table opens half an hour before the course begins.
CDE Credits
6 hours (Lecture and Hands-On)
Please bring lab jacket and safety glasses for the hands-on portion of the course.
Registration Policy
For your convenience you may register up until 3:00 p.m. on the day prior to the start of the course with no additional charge. An additional non-refundable fee of $20 dollars per person, per course will be assessed to any registrations received after 3:00 p.m. the day prior to a course or to any same day or walk in registrations.
Refund and Cancellation Policy
Unless otherwise posted, a full refund less $25 will be granted if notification of cancellation is received by the Institute for Advanced Continuing Dental Education office two weeks (14 or more days) prior to the start of the course. If a cancellation is received less than two weeks (13 or less days) prior to the start of a hands-on course, no refund will be granted. Refunds cannot be given for same any day cancellations or no-shows.
Click here to visit our updated general information and policy page.
This course is sponsored in part by unconditional educational grant from Biomet 3i.


text:
You are here
Charleston Tells Storytelling Festival
Date & Time
Friday, March 14, 2014 - 7:00pm to Saturday, March 15, 2014 - 10:00am
Wragg Square, 342 Meeting St.
Event Details
Lose yourself in a weekend of stories told by professional storytellers from Charleston and across the nation. Charleston County Public Library presents a festival designed to bring out your inner child as you learn about the city's rich heritage and participate in the tradition of oral history. Locals and visitors alike enjoy two days of immersion into culture and stories from the Holy City's past. Wragg Square, 342 Meeting St. Friday & Saturday, 7am & 10am. $40-$15. (843)805-6930, www.facebook.com/CharlestonTells


text:
- FTSE 100 Companies
- SMEs
- National Government
- Local Government and Agencies
- Police and Fire Services
- Hospitals and NHS Trusts
- Schools and Educational Establishments
We offer a high-quality, personal service independent from the manufacturer, including:
- 24x7 support
- 4-hour / 8-hour and next-business-day cover
- Mix and match SLA approach
Our highly-skilled engineers have high-level security clearance and will support your hardware way beyond manufacturer end-of-life.
How Com-Com Reduces Your CostsOrganisations are under pressure to get better value from their IT spend and reduce their impact on the environment. We help our customers to do this in a number of ways:
Reducing capital expenditureBy extending the life of your Dell servers, you can delay and reduce your capex. Our Dell parts supply and Dell maintenance services extend your servers lives well beyond the support offered by the manufacturer.
Reducing operating costsOur Dell server maintenance service will save you 40% on the equivalent service from the manufacturer. Outsourcing systems administration and operating system support to us lowers your costs further, helps you to free up resources for other projects and gives you extra cover during sickness and holidays.
Environmental savingsWe are all aware how much energy it takes to manufacture equipment - often more than is ever consumed during its lifetime. If you can extend the life of your hardware by a year or two from say four years to six, then you may reduce that impact by a third. With virtualization you can eliminate many of your physical servers, reducing the need for new hardware and the power and cooling required to run them.
Supply and installation of Dell hardware upgradesIf you need hardware upgrades for your Dell hardware, Com-Com can specify, provide, install and configure them for you. These upgrades can be supplied no matter how old the equipment is - we have even supplied and set up upgrades for systems over 30 years old.
Other Com-Com value-added services
- Disaster recovery
- Equipment disposal
- Data destruction
- Practical software support
- Virtualisation
Dell platform support services
|PowerVault disk and tape
|PowerConnect Networking
|Storage: EMC, AX, MD, RD and EqualLogic
|Our four standard SLAs (Service Level Agreement) are:
CALL US NOW TO FIND OUT MORE+44 208 885 9900 ORcontact our sales team


text:
Log In now to add this Gigapan to a group gallery.
Log In now to add this Gigapan to a gallery.
About This GigapanToggle
- Taken by
- Richard Palmer
- Explore score
- 7
- Size
- 1.52 Gigapixels
- Views
- 7950
- Date added
- Jun 25, 2008
- Date taken
- Jun 24, 2008
- Gear
Gigapan Beta2 with Canon S5-IS
- Categories
- Galleries
- Competitions
- Tags
- arboretum, lyon, recovery, conservation, culture, tissue, endangered, hawaii, fofs, restoration
- Description
Many of the test tubes in this growing room contain tissue culture propagules/sterile culture seedlings of many of Hawai`i's rarest plants. A number of the species represented here have fewer than 10 individual plants remaining in the wild; a few with no known living wild specimens. Hawai`i comprises just 0.2% (1/500) of the land area of the United States, but harbors nearly 1/3 of the threatened and endangered plant and animal species in the entire country.
I set the white balance and exposure for this panorama, and used auto focus. There are a few auto focus artifacts evident - see if you can find them.
Gigapan Comments (0)Toggle Minimize gigapan_comment
Where in the World is this GigaPan?Toggle
Stitcher NotesToggleMinimize
All default settings
Original image properties:
Camera make: Canon
Camera model: Canon PowerShot S5 IS
Image size: 3264x2448 (8.0 megapixels)
Aperture: f/8
Exposure time: 0.05
Focal length (35mm equiv.): 152.5 mm
Digital zoom: off
White balance: Fixed
Exposure mode: Manual
Has subsecond timestamp: no
Horizontal overlap: 27.4576 - 60.9269 percent
Vertical overlap: 28.1425 - 38.0612 percent
Version 0.3.2260 (Windows)
Panorama size: 1515 megapixels (51622 x 29351 pixels)
Input images: 357 (21 x 17)
Field of view: 200.327 degrees wide by 113.901 degrees high (55.5166--58.3844)
Computer stats: 3061.54 MB RAM, 2 CPUs
Total time 6:04:30 (1:01 per picture)
Alignment: 30:39, Projection: 28:22, Blending: 5:05:28


text:
SQ2040-2F16-WiFi Portable Wireless Universal Input Data Logger
Squirrel 2040 series offers high performance universal data loggers packed with powerful features to provide great flexibility to handle a wide range of routine and demanding applications.
- Up to 32 universal inputs for voltage, current or resistance
- Up to 8 inputs for digital pulse and event
- Inputs can be used with thermistor, thermocouple and RTD temperature sensors and 4-20mA instruments
- Built-in 802.11b wireless Ethernet interface
- Sub-second logging and concurrent sampling
- 16 MB of internal memory for approximately 1,000,000 to 2,000,000 readings
- Download to removable MMC (Multi Media Card) memory
- Easy to use removable connector system
- Power outputs for use with external devices
- Comprehensive access to information using the 2-line x 40-character LCD and button panel
- Readings can be scaled into meaningful engineering units (e.g. m/sec, ppm)
- Calculated channels
- USB and RS-232 Communication
- Ethernet Interface – 2F8 model only
- Non-volatile flash memory – data retention is virtually indefinite
- Multiple 24-bit analog-to-digital converters (ADC) for precision measurements
- Portable, battery-operated, or mains powered
- View More Information


text:
Nostalgia Electrics RSM-650 $59.99
Retro Series Slush Drink Maker
$74.99 Save: $15.00
+ FREE Shipping
Hurry, sale ends Monday!
List Price: $74.99
Save: $15.00 (20% Off)
+ FREE Shipping
Usually Ships in 3 - 4 Business Days
1-866-975-4846Talk with an Expert
Description & Highlights
Nostalgia Electrics Retro Series Slush Drink Maker - Red
The Nostalgia Electrics Retro Series Slush Drink Maker (RSM-650) is perfect for outdoor entertaining! Using crushed ice or small ice cubes from your freezer, ordinary table salt and a little water, plus your favorite fruit juice, you can enjoy hours of fun with delicious slush drinks.
This drink maker features an easy-to-use serving dispenser for mess-free pours, and the clear liquid box lets you watch as you make your favorite slushy concoctions. The retro styling looks great at a party or on your counter.
Retro Design:Designed after old-fashioned 50's diners, this drink maker looks great on your countertop or at any party
Easy to Use:Just add ice, salt, water, and juice for delicious slushies that are ready in a heartbeat
Front Pour Spout:The convenient front-mounted serving spout eliminates messy pours and makes dispensing a breeze
- Model: RSM-650Nostalgia Electrics Retro Series Slush Drink Maker
- Brand: Nostalgia ElectricsMakes slush drinks from ice, water, salt, and juice
- Front-mounted serving spoutInput voltage: 120V / 60Hz
- Clear polycarbonate beverage containerWeight: 4 lbs
- Warranty: 90 days limited on partsDimensions: 17" H x 7.75" W x 7.75" D
- Height: 17"
- Width: 7.75"
- Depth: 7.75"


text:
There whould be OpenSource/FreeSource developers/users informal meeting in Ukraine/Kiev on 17.05.2003
You should be on 11:00 at M. Geroev Dnepra. (or just contact staff at www.osdn.org.ua).
Don't you think it is a lot like money. Someone pay you salary (that means he trusts you that mach to be usefull for community) and then it's up to you to distribute this money to other people, pay for bills, restorants etc (that means you have ability to rate them as "usefull for community" - for yourself in first place).
Still it is not clear should you be trusted to rate other people this way? May you give all your money to someone just becouse you like it? Is it you personal disision or it is not (becouse it whould meant that you trus that person "to be usefull for community").
Now you are. Same with TM. It is not argent yet to deside, but it will be if you'll try to use TM as universal trust equivalent (mail filtering, access etc).


text:
Jon Stewart vs. Bill O'Reilly. Please take a look, I'm interested to hear reactions from both sides:
Jon Stewart vs. Bill O'Reilly. Please take a look, I'm interested to hear reactions from both sides:
Thanks for the link. Wanted to watch it last night but got home late. Heard the internet stream failed anyways.
Love it. Thought they both did well, made alot of good points. Admittedly felt like Stewart "won" it, but that could be bias.
Loved Stewarts opening line and O'Riellys flash cards(Waterboard=bad, Drones=good).
Terrorist attack count against the Anything Goes Thread: 5
---------- Post added at 02:29 PM ---------- Previous post was at 02:28 PM ----------
It's really not about one side "winning" or not for me, I just want to have a frank honest discussion about issues between people who know what there talking about. And that's what this was.
I stopped watching when I saw that Stewart confused the deficit with the debt. I'll still watch it later, but I thought that was pretty sad.
Um... Stewart should be embarrassed for that.
Privatizing gains & socializing losses was a good line.
I was absolutely hilarious. They both did a great job.


text:
The Purchasing Department seeks to support the University of Dallas and all its departments, inclusive of staff, faculty, and ancillary offices through the timely acquisition of materials and services. Through negotiations, analysis, and continual review of market conditions, Purchasing's sole objective is to provide the best value for the University. It shall operate under the professional standards established by the University of Dallas and the guidelines set by the Institute of Supply Chain.
The Purchasing Department has in excess of forty years of Supply Chain Management
which includes:
These skills have been honed from experience in a variety of industries including education, telecommunications, construction, manufacturing, and convention management. The staff continually reviews standard practices to maintain consistence with the standards set by the Institute Supply Chain management and University policy.


text:
Cro Cop Final Fight Open Workouts: Daniel Ghita and Igor Jurkovic
- Written by Rian Scalia
Cro Cop Final Fight is two days away and yesterday the press conference was held in Zagreb. Today was the open workouts that featured Daniel Ghita and Igor Jurkovic ahead of their fights on Saturday. Mirko Cro Cop could not be present at the open workouts as he encountered some personal problems but he will be at the weigh in tomorrow. The video just consists of both fighters hitting mitts but it's always interesting to see fighters train. Jurkovic and Ghita both looked strong and poised for their fights at the Zagreb Arena on Saturday.


text:
The A.A.S degree in process technology prepares you for employment as an operations technician in the process industry. The process industry includes oil and gas production, mining and milling, transportation and refining, utilities, wastewater treatment and facilities maintenance. These are highly skilled and well paid positions within Alaska and around the world.
Program Overview
The process technology program combines the technical courses you need to become well versed in the process industry with the academic courses you need to obtain your degree and prepare for a successful career. The courses cover topics from pumps and turbines to instrumentation, safety and quality control. A valuable part of the program comes from summer internships provided by British Petroleum, Flint Hills Resources, and Alyeska Pipeline Service Company, giving you the opportunity to gain practical experience and exposure to a wide variety of career options. Our instructors bring years of experience from various fields within the processing industry with them to the classroom. In addition to textbook learning and lectures, you will receive training on equipment that is current with industry standards.
In addition to textbook learning and classroom lectures, students train and practice on equipment and models that are current with industry standards. The instructors bring with them years of experience from various fields within the processing industry. Class sizes are small to ensure students receive valuable one-on-one interaction with the instructors as well as ample time to work on the equipment.
The Process Technology Program is located in the Fairbanks Pipeline Training Center, 3600 Cartwright Court, off of Van Horn Road in Fairbanks.
Job Opportunities
Process technicians/operators may work in many industries including: oil and gas production; chemical manufacturing; petroleum refining; mining and milling; power generation and utilities; waste and wastewater treatment; and seafood and other food processing industries. Job responsibilities of the process technician include monitoring and controlling process systems; maintaining safe work areas and regulatory compliance; assigning maintenance to craft technicians and coordinating repairs; troubleshooting operations and testing the product for quality ; monitoring the instrumentation and controls associated with their area of responsibility; interfacing with support technicians; and supervising computer or analog automatic control equipment. Technicians may work both indoors and outdoors with process equipment, piping, and material transfers making this an exciting and challenging career choice. Entry-level salary ranges are from $45,000 to $72,000 annually.
Scholarship Opportunities
The Alaska Process Industry Careers Consortium (APICC) and the First Alaskans Foundation have scholarships available for Alaska Native students pursuing a degree in process technology. In addition, scholarships are available from British Petroleum for college-bound students as well as those interested in careers in process technology. Scholarship applications are generally due during the spring semester. Visit the APICC website for more information.
Contact Information:
Brian Ellingson, Program Coordinator
Fax: 479-2134
Process Technology
UAF Community and Technical College
P.O. Box 758080
Fairbanks, Alaska 99775
Department e-mail: email@example.com
Facebook: www.facebook.com/UAFProcessTech


text:
Hello, there, I heard a rumor at the Megacon here in orlando that the New Jedi Order book series is going to be turned into a comic book series sometime next year. The only new comic book stories with Han, Luke and the rest that take place after the Empire's End series was 'Union', and that was kind of disappointing.
I am reading the New Jedi Order books now and am up to the 4th book in the series.


text:
IBM Certified System Administrator - WebSphere MQ V7.0
Job Role Description / Target Audience
Note: This certification will be withdrawn on 05/31/2016. The most current certification is: IBM Certified System Administrator - MQ V8.0
This intermediate level system administrator is an individual with extensive product knowledge, who is expected to plan, install, and configure the product as well as implement applications, set up distributed queuing, enable appropriate security, administer and operate a queue manager network, enforce organizational and operational standards, perform basic problem determination and implement clustering and publish/subscribe topologies.
It is expected that this system administrator will be generally self-sufficient and be able to perform the tasks involved in the role with limited assistance from peers, product documentation and vendor support services.
Due to the various platforms supported by WebSphere MQ V7.0, this certification is a cross platform certification.
To attain the IBM Certified System Administrator - WebSphere MQ V7.0 certification, candidates must possess the skills outlined under Recommended Prerequisites below and pass 1 test. To prepare for this test, based on the job role and test objectives, click the link to Test C2180-374 below, and refer to the Test preparation tab.
Recommended Prerequisite Skills
(Knowledge and skills one needs to possess before beginning to prepare for this job role certification; skills not measured on the test)
- Working knowledge of WebSphere MQ
- Working knowledge of supported operating systems (e.g., AIX, HP-UX, Solaris, i5/OS, Linux on Intel, Linux on zSeries, z/OS, Windows)
- Good understanding of messaging concepts as they relate to IBM WebSphere MQ
- Basic knowledge of operating WebSphere MQ Explorer
- Basic understanding of JMS concepts
- Basic knowledge of networking concepts (e.g., TCP/IP, SSL, etc.)
This certification requires 1 test(s).
Test(s) required:
Click on the link(s) below to see test details, test objectives, suggested training and sample tests.
Each test:
- contains questions requiring single and multiple answers. For multiple-answer questions, you need to choose all required options to get the answer correct. You will be advised how many options make up the correct answer.
- is designed to provide diagnostic feedback on the Examination Score Report, correlating back to the test objectives, informing the test taker how he or she did on each section of the test. As a result, to maintain the integrity of each test, questions and answers are not distributed
Member Site
Not sure what the Member site is? Find out the benefits of being a certified professional.
Premium Wallet Card
Receive a premium wallet when you order your Premium Certificate.